NCMW
ALXN

Northern Capital Management (Wisconsin)’s Alexion Pharmaceuticals ALXN Stock Holding History

Northern Capital Management (Wisconsin)’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$651K Sell
6,690
-50
-0.7% -$5.91K 0.17% 138
2018
Q3 		$937K Sell
6,740
-1,720
-20% -$216K 0.22% 121
2018
Q2 		$1.05M Buy
8,460
+1,315
+18% +$154K 0.26% 120
2018
Q1 		$796K Buy
7,145
+2,375
+50% +$284K 0.21% 126
2017
Q4 		$570K Buy
+4,770
New +$581K 0.15% 144

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Capital Management (Wisconsin)'s ALXN Position: Q4 2018 in Review

Northern Capital Management (Wisconsin) reduced its Alexion Pharmaceuticals (ALXN) stake by 0.74% in Q4 2018, selling an estimated $5.91K and leaving 6,690 shares worth $651K. The position accounts for 0.17% of the portfolio, ranked #138.

Northern Capital Management (Wisconsin) first reported a position in ALXN in Q4 2017 and has held it in 5 quarters since. The position peaked at $1.05M in Q2 2018. 609 funds tracked by Wall St. Rank hold ALXN as of Q4 2018.

  • Northern Capital Management (Wisconsin) held 6,690 shares of Alexion Pharmaceuticals worth $651K as of Q4 2018.
  • Northern Capital Management (Wisconsin) sold 50 Alexion Pharmaceuticals shares in Q4 2018, an estimated $5.91K.
  • Alexion Pharmaceuticals made up 0.17% of Northern Capital Management (Wisconsin)'s portfolio in Q4 2018, its #138 holding.
  • Northern Capital Management (Wisconsin) first reported a position in Alexion Pharmaceuticals in Q4 2017 and has held it in 5 quarters since.
  • Northern Capital Management (Wisconsin)'s Alexion Pharmaceuticals position peaked at $1.05M in Q2 2018.
  • 609 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2018.

Based on Northern Capital Management (Wisconsin)'s 13F filing for Q4 2018, filed 1 Feb 2019.